J&J’s Billion-Dollar Robot Bet
Johnson & Johnson has received FDA approval for its new surgical robot, Ottava, after years of development and billions of dollars in investment. This follows a complex journey including a previous version's delay and acquisitions of companies like Auris Health. While J&J enters a market dominated by competitors like Intuitive, they believe Ottava's integrated, table-based design offers a unique advantage, particularly in operating rooms where space is limited.
The approval of Ottava marks a significant entry by a major healthcare company into the growing robotic surgery market, potentially challenging established players and impacting surgical training and patient care.
JOHNSON & JOHNSON OTTAVA FDA APPROVAL ROBOTIC SURGERY INTUITIVE SURGICAL